XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue        
Total revenue, net $ 41,494 $ 28,191 $ 75,903 $ 49,816
Operating expenses        
Cost of sales 1,563 1,599 1,984 1,855
Selling, general and administrative 47,081 51,532 97,205 96,729
Research and development 12,650 11,525 25,808 24,145
Other (income) expense, net (3,630) (476) (3,340) 958
Total cost of sales and operating expenses 57,664 64,180 121,657 123,687
Loss from operations (16,170) (35,989) (45,754) (73,871)
Interest expense (65) 0 (65) 0
Interest income 4,101 483 7,915 745
Net loss before income taxes (12,134) (35,506) (37,904) (73,126)
Income tax (benefit) expense (642) 9 (206) 19
Net loss (11,492) (35,515) (37,698) (73,145)
Other comprehensive loss:        
Unrealized (loss) gain on available-for-sale securities, net of tax of nil (32) (235) 41 (1,001)
Comprehensive loss $ (11,524) $ (35,750) $ (37,657) $ (74,146)
Basic loss per share (in usd per share) $ (0.08) $ (0.25) $ (0.26) $ (0.52)
Diluted loss per share (in usd per share) $ (0.08) $ (0.25) $ (0.26) $ (0.52)
Weighted-average common shares outstanding used in computation of basic loss per share (in shares) 142,777 141,726 142,904 141,734
Weighted-average common shares outstanding used in computation of diluted loss per share (in shares) 142,777 141,726 142,904 141,734
Product revenue, net        
Revenue        
Total revenue, net $ 41,100 $ 28,148 $ 75,437 $ 49,640
License, royalty and collaboration revenue        
Revenue        
Total revenue, net $ 394 $ 43 $ 466 $ 176